CRISPR Therapeutics to present at Bank of America 2026 Global Healthcare Conference on May 12.

CRISPR Therapeutics announced that its senior management will present at the Bank of America Securities 2026 Global Healthcare Conference on May 12, 2026. The presentation will include a live webcast accessible on the company's website, with a replay available for 14 days. CRISPR Therapeutics is a leading biopharmaceutical company known for pioneering CRISPR/Cas9 gene editing and recently achieved a milestone with the approval of CASGEVY®, the first CRISPR-based therapy for sickle cell disease and beta thalassemia. The company continues to advance a diverse pipeline and expand its gene editing technologies through strategic partnerships, including with Vertex Pharmaceuticals.